PROCEPT BioRobotics (PRCT)
NASDAQ:PRCT
US Market
Holding PRCT?
Track your performance easily

PROCEPT BioRobotics (PRCT) Ownership - Who Owns PROCEPT BioRobotics?

297 Followers

PROCEPT BioRobotics (PRCT) Ownership Overview

10.21%35.90%3.74%15.24%34.91%
10.21% Insiders
3.74% Other Institutional Investors
15.24% ETFs
34.91% Public Companies and Individual Investors
The ownership structure of PROCEPT BioRobotics (PRCT) stock is a mix of institutional, retail, and individual investors. Approximately 54.88% of the company’s stock is owned by Institutional Investors, 10.21% is owned by Insiders, and 34.91% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Oct 31, 2024
Reza Zadno
President & Ceo,director
xxxxxxxxxxxxx
$26249951
May 03, 2024
Alaleh Nouri
Evp, Clo, Corp. Sec
xxxxxxxxxxxxx
$1916428
Mar 20, 2024
Reza Zadno
President & Ceo,director
xxxxxxxxxxxxx
$263243
Mar 20, 2024
Kevin Waters
Evp, Cfo
xxxxxxxxxxxxx
$50002

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,656,348Institution8.56%461,304,396
4,166,647Institution7.66%412,789,718
3,780,460Insider6.95%374,530,172
2,108,765Institution3.88%208,915,349
1,981,550Institution3.64%196,312,159
1,500,000Institution2.76%148,605,000
1,063,289Institution1.95%105,340,041
926,649Institution1.70%91,803,116
809,609Insider1.49%80,207,964
635,508Institution1.17%62,959,778

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
4,166,647Institution7.66%412,789,718
2,108,765Institution3.88%208,915,349
1,500,000Institution2.76%148,605,000
1,063,289Institution1.95%105,340,041
926,649Institution1.70%91,803,116
582,623Institution1.07%57,720,461
525,000Institution0.97%52,011,750
487,963Institution0.90%48,342,494
476,230Institution0.88%47,180,106
473,081Institution0.87%46,868,135

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,563,409Institution2.87%125,260,329
1,155,323Institution2.12%114,457,850
1,234,851Institution2.27%98,936,262
767,117Institution1.41%61,461,414
575,263Institution1.06%55,357,558
681,149Institution1.25%54,573,658
382,210Institution0.70%37,865,545
293,848Institution0.54%29,111,521
247,930Institution0.46%23,858,304
194,310Institution0.36%15,568,117

FAQ

Who Owns PROCEPT BioRobotics (PRCT)?
According to the latest TipRanks data, approximately 3.74% of the company's stock is held by institutional investors, 10.21% is held by insiders, and 34.91% is held by retail investors.
    What percentage of PROCEPT BioRobotics (PRCT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 3.74% of PROCEPT BioRobotics (PRCT) stock is held by institutional investors.
      What percentage of PROCEPT BioRobotics (PRCT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 34.91% of PROCEPT BioRobotics (PRCT) stock is held by retail investors.
        Who owns the most shares of PROCEPT BioRobotics (PRCT)?
        Vanguard owns the most shares of PROCEPT BioRobotics (PRCT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis